Concepedia

N‐terminal‐probrain natriuretic peptide as a biomarker of moderate to severe bronchopulmonary dysplasia in preterm infants: A prospective observational study

Silvia Rodríguez‐Blanco, Ignacio Oulego‐Erroz, Paula Alonso‐Quintela, Sandra Terroba‐Seara, Aquilina Jiménez‐González, Maite Palau‐Benavides

Pediatric Pulmonology · 2018 · 26 citations · 23 references

DOI

Abstract

The NT-proBNP levels at 5-10 days of life may identify preterm infants with an HsPDA who are at high risk of BPD or death and may be useful for individualized preventive and therapeutic strategies.

References

23

Pediatric Pulmonary Hypertension

Steven H. Abman, Georg Hansmann, Stephen L. Archer et al. · Circulation · 2015 · 1.1K citations

, , +16

The EPICure Study: Outcomes to Discharge From Hospital for Infants Born at the Threshold of Viability

Kate Costeloe, Enid Hennessy, Alan T. Gibson et al. · PEDIATRICS · 2000 · 994 citations

Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or less

Álvaro González, Ilene R S Sosenko, Jay Chandar et al. · The Journal of Pediatrics · 1996 · 301 citations

, , +8

Utility of Rapid B-Type Natriuretic Peptide Assay for Diagnosis of Symptomatic Patent Ductus Arteriosus in Preterm Infants

Byung Min Choi, Kee Hyoung Lee, Baik Lin Eun et al. · PEDIATRICS · 2005 · 141 citations

Brain-Type Natriuretic Peptide in the Diagnosis and Management of Persistent Pulmonary Hypertension of the Newborn

E. W. Reynolds, Jeff G. Ellington, Mark Vranicar et al. · PEDIATRICS · 2004 · 139 citations